» Articles » PMID: 30188611

Generation of the UFM1 Toolkit for Profiling UFM1-Specific Proteases and Ligases

Overview
Specialty Chemistry
Date 2018 Sep 7
PMID 30188611
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Ubiquitin-fold modifier 1 (UFM1) is a reversible post-translational modifier that is covalently attached to target proteins through an enzymatic cascade and removed by designated proteases. Abnormalities in this process, referred to as Ufmylation, have been associated with a variety of human diseases. Given this, the UFM1-specific enzymes represent potential therapeutic targets; however, understanding of their biological function has been hampered by the lack of chemical tools for activity profiling. To address this unmet need, a diversifiable platform for UFM1 activity-based probes (ABPs) utilizing a native chemical ligation (NCL) strategy was developed, enabling the generation of a variety of tools to profile both UFM1 conjugating and deconjugating enzymes. The use of the probes is demonstrated in vitro and in vivo for monitoring UFM1 enzyme reactivity, opening new research avenues.

Citing Articles

Chemical approaches to explore ubiquitin-like proteins.

Mousa R, Shkolnik D, Alalouf Y, Brik A RSC Chem Biol. 2025; .

PMID: 39950163 PMC: 11817102. DOI: 10.1039/d4cb00220b.


Chemical Tools for Probing the Ub/Ubl Conjugation Cascades.

Kochanczyk T, Fishman M, Lima C Chembiochem. 2024; 26(1):e202400659.

PMID: 39313481 PMC: 11727022. DOI: 10.1002/cbic.202400659.


Total Chemical Synthesis of LC3A and LC3B Activity-Based Probes.

Huppelschoten Y, Buchardt J, Nielsen T, Sapmaz A, van der Heden van Noort G Biomedicines. 2023; 11(3).

PMID: 36979862 PMC: 10045837. DOI: 10.3390/biomedicines11030884.


A guide to UFMylation, an emerging posttranslational modification.

Millrine D, Peter J, Kulathu Y FEBS J. 2023; 290(21):5040-5056.

PMID: 36680403 PMC: 10952357. DOI: 10.1111/febs.16730.


Facile Preparation of UFMylation Activity-Based Probes by Chemoselective Installation of Electrophiles at the C-Terminus of Recombinant UFM1.

Tolmachova K, Farnung J, Liang J, Corn J, Bode J ACS Cent Sci. 2022; 8(6):756-762.

PMID: 35756382 PMC: 9228560. DOI: 10.1021/acscentsci.2c00203.


References
1.
Oweis W, Padala P, Hassouna F, Cohen-Kfir E, Gibbs D, Todd E . Trans-Binding Mechanism of Ubiquitin-like Protein Activation Revealed by a UBA5-UFM1 Complex. Cell Rep. 2016; 16(12):3113-3120. DOI: 10.1016/j.celrep.2016.08.067. View

2.
Komatsu M, Chiba T, Tatsumi K, Iemura S, Tanida I, Okazaki N . A novel protein-conjugating system for Ufm1, a ubiquitin-fold modifier. EMBO J. 2004; 23(9):1977-86. PMC: 404325. DOI: 10.1038/sj.emboj.7600205. View

3.
Lu H, Yang Y, Allister E, Wijesekara N, Wheeler M . The identification of potential factors associated with the development of type 2 diabetes: a quantitative proteomics approach. Mol Cell Proteomics. 2008; 7(8):1434-51. PMC: 2500228. DOI: 10.1074/mcp.M700478-MCP200. View

4.
Ekkebus R, van Kasteren S, Kulathu Y, Scholten A, Berlin I, Geurink P . On terminal alkynes that can react with active-site cysteine nucleophiles in proteases. J Am Chem Soc. 2013; 135(8):2867-70. PMC: 3585465. DOI: 10.1021/ja309802n. View

5.
Ogunkoya A, Pattabiraman V, Bode J . Sequential α-ketoacid-hydroxylamine (KAHA) ligations: synthesis of C-terminal variants of the modifier protein UFM1. Angew Chem Int Ed Engl. 2012; 51(38):9693-7. DOI: 10.1002/anie.201204144. View